Jane Street Group, LLC Seagen Inc. Call Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$119.61 - $157.85 $5.35 Million - $7.06 Million	-44,700 Reduced 45.02%	54,600 $7.87 Million
Q4 2021 Feb 15, 2022	BUY	$142.57 - $190.86 $1.68 Million - $2.25 Million	11,800 Added 13.49%	99,300 $15.4 Million
Q3 2021 Nov 16, 2021	SELL	$142.45 - $169.82 $5.63 Million - $6.71 Million	-39,500 Reduced 31.1%	87,500 $14.9 Million
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $12.6 Million - $15 Million	93,200 Added 275.74%	127,000 $20.1 Million
Q1 2021 May 18, 2021	SELL	$137.51 - $190.8 $13.6 Million - $18.8 Million	-98,600 Reduced 74.47%	33,800 $4.69 Million

Q4 2020 Feb 17, 2021	BUY	$164.63 - $211.93 $21.8 Million - $28.1 Million	132,400 New	132,400 $23.2 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.